InFinT Acquisition 

$6.28
12
-$3.72-37.2% Friday 19:58

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
36.94
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 7
$0.03
May 7
$0.03
Feb 7
$0.03
Nov 6
$0.02
Aug 6
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

9NovExpected
Q3 2021
Q4 2021
Q3 2022
-0.01
-0.01
-0
0
Expected EPS
N/A
Actual EPS
-0.01

Financials

-Profit Margin
Profitable
2021
2022
2023
0Revenue
6.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IFIN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Avenir, making them direct competitors in the healthcare market.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm focusing on novel therapies, including treatments for conditions that Avenir Wellness Solutions also targets.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a diverse product portfolio that includes medications in direct competition with those of Avenir Wellness Solutions.
Merck
MRK
Mkt Cap214.76B
Merck operates globally in pharmaceuticals, including areas like immunotherapy and oncology, competing with Avenir's product lines.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie offers a range of biopharmaceuticals that directly compete with Avenir Wellness Solutions in multiple therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb, with its broad range of pharmaceutical products, competes in the same market segments as Avenir Wellness Solutions.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company produces medicines in areas such as mental health and diabetes, overlapping with Avenir's market interests.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that produces drugs that directly compete with Avenir Wellness Solutions' offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson has a large portfolio of pharmaceuticals that includes competitive products in the wellness and therapeutic sectors targeted by Avenir.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in areas like immunology and oncology, which are key focus areas for Avenir Wellness Solutions.

About

Currenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.
Show more...
CEO
Employees
2
Country
KY
ISIN
KYG478621009

Listings

0 Comments

Share your thoughts

FAQ

What is InFinT Acquisition stock price today?
The current price of IFIN is $6.28 USD — it has decreased by -37.2% in the past 24 hours. Watch InFinT Acquisition stock price performance more closely on the chart.
What is InFinT Acquisition stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange InFinT Acquisition stocks are traded under the ticker IFIN.
What were InFinT Acquisition earnings last quarter?
IFIN earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is InFinT Acquisition revenue for the last year?
InFinT Acquisition revenue for the last year amounts to 0 USD.
What is InFinT Acquisition net income for the last year?
IFIN net income for the last year is 6.3M USD.
Does InFinT Acquisition pay dividends?
Yes, IFIN dividends are paid quarterly. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does InFinT Acquisition have?
As of April 02, 2026, the company has 2 employees.
In which sector is InFinT Acquisition located?
InFinT Acquisition operates in the Other sector.
When did InFinT Acquisition complete a stock split?
The last stock split for InFinT Acquisition was on June 17, 2002 with a ratio of 2:1.